Small Primary Cutaneous γδT-Cell Lymphoma Lesions Successfully Treated With Pralatrexate. (February 2019)

• Record Type: Journal Article
• Authors: Imataki, Osamu; Uchida, Shumpei; Yokokura, Shigeyuki; Uemura, Makiko; Kadowaki, Norimitsu
• Is Part Of: Clinical nuclear medicine. Volume 44:Number 2(2019)
• Publication Date: 2019-02
• Subjects: primary cutaneous γδT-cell lymphoma -- pralatrexate -- cutaneous T-cell lymphoma -- PET -- 18F-fluorodeoxyglucose -- spatial resolution; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000002409
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: Here we report on the treatment of a 38-year-old woman with primary cutaneous γδT-cell lymphoma, which is a rare subset of cutaneous T-cell lymphoma. She presented with multiple subtle subcutaneous nodules, which were not clearly observed on computed tomography scans or after biopsy. However, 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET) accurately detected small cutaneous lesions. She achieved a second complete remission, as demonstrated by 18 F-FDG-PET performed after pralatrexate infusion.